Stay updated on Dupilumab Efficacy in CRSsNP: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.

Latest updates to the Dupilumab Efficacy in CRSsNP: Clinical Trial page
- Check5 days agoChange DetectedThe plain language Results Summary, sponsor credit for Sanofi, and the 'Helpful Links Provided by' label were removed from the Study Details page. This results in a leaner page presentation while keeping the essential study information intact.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now shows revision v3.6.5, replacing v3.6.4. This indicates an internal update without changes to the visible content.SummaryDifference0.0%

- Check20 days agoChange DetectedThe study phase has been updated to Phase 2 and Phase 3 has been removed, reflecting a change in the trial’s phase status. Recent July 2026 update dates indicate the record was revised.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, signaling a new release of the study details page. The update likely reflects a small adjustment to the page’s content or user interface rather than substantive study information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the study record's documentation.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor update to the ClinicalTrials.gov page. No substantive changes to the study details or content appear to be included.SummaryDifference0.0%

Stay in the know with updates to Dupilumab Efficacy in CRSsNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.